ABSTRACT Inclusion body hepatitis-hydropericardium syndrome (IBH-HPS) caused by fowl adenovirus type 4 (FAdV-4) has caused huge economic losses for China in the past five years. At present, this disease is controlled in many flocks with the inactivated FAdV vaccine, but the offspring chicks of a layer breeding flock that were vaccinated with this vaccine still became infected and developed IBH-HPS with a 20% mortality rate. Analysis revealed that the NDV-attenuated vaccine in use from the above-mentioned poultry farm was simultaneously contaminated with FAdV-4 and chicken infectious anemia virus (CIAV). The FAdV and CIAV isolated from the vaccine were purified for the artificial preparation of an NDV-attenuated vaccine singly contaminated with FAdV or CIAV, or simultaneously contaminated with both of them. Seven-day-old layers with maternal FAdV antibody were inoculated with the artificially prepared, contaminated vaccines and assessed for corresponding indices. The experiments showed that no obvious symptoms occurred after using the NDV-attenuated vaccine singly contaminated with FAdV or CIAV; however, common IBH and occasional HPS-related death was found in birds after administering the NDV-attenuated vaccine co-contaminated with FAdV and CIAV. In conclusion, this study illustrated that CIAV could assist FAdV in breaking maternal FAdV antibody protection, which then caused the IBH-HPS after vaccination with the co-contaminated NDV vaccine.
INTRODUCTION
Since 2013, an avian disease characterized by fluid accumulation in the pericardial sac with inclusion body hepatitis had appeared in Shandong, Henan, Hebei, and other provinces of China, and has been named as inclusion body hepatitis-hydropericardium syndrome (IBH-HPS). After a large number of epidemiological investigations (Liu et al., 2016; Chen et al., 2017; Pan et al., 2017) , the etiology was determined to be fowl adenovirus type 4 (FAdV-4). To control the FAdV-4 epidemic, most flocks received inactivated FAdV-4 vaccines, which not only protected parental chickens against FAdV but also their offspring chicks by maternal antibodies.
However, in the first half of 2015, an outbreak of FAdV-4 infection and IBH-HPS appeared in offspring chicks of parental chickens that had been vaccinated with the inactivated FAdV vaccine in a large scale layer farm. Investigations revealed that the attenuated Newcastle disease virus (NDV) vaccine from this farm was contaminated with both FAdV-4 and chicken infectious anemia virus (CIAV), which might be an important reason for the outbreak of IBH-HPS in this layer flock.
Exogenous virus contamination in avian-attenuated vaccine is a unique source of infection for some infectious diseases. But usually, the dose of exogenous virus in the vaccine is extremely low, and many people believed that the maternal antibodies could still protect chicks against FAdV, especially during the time that vaccinations were being performed. Meanwhile, it is well known that CIAV or infectious bursal disease virus can enhance FAdV pathogenicity (Fadly et al., 1976; Toro et al., 2000 Toro et al., , 2001 . Thus the effects of CIAV 621 on FAdV spiked our interest, and in vivo animal experiments were launched to study the pathogenicity of attenuated NDV vaccines contaminated with those viruses on chicks with FAdV maternal antibodies.
MATERIALS AND METHODS

Ethics Statement
The animal care and use protocol was approved by the Shandong Agricultural University Animal care and use Committee (SDAUA-2016-002) . All of the experimental animals of this study were cared for and maintained throughout of the experiments strictly following the ethics and biosecurity guidelines approved by the Institutional Animal Care and Use Committee of Shandong Agricultural University.
Virus and Vaccine Background
In the first half of 2015, about 20% mortality rate from severe IBH-HPS appeared on a large-scale layer farm, while parental chickens of those layers had vaccinated inactivated FAdV vaccine. To ensure the association between the disease and vaccine contamination, corresponding real time fluorescence quantitative polymerase chain reactions (qPCR) were launched for the detection of avian leukosis virus (ALV), reticuloendotheliosis virus (REV), FAdV, and CIAV in the attenuated vaccines from this farm (Günes et al., 2012; Dai et al., 2015; Luan et al., 2016; Ren et al., 2016) . Surprisingly, the results showed the cocontamination of FAdV and CIAV in the same NDV attenuated vaccine, which might have caused the outbreak of IBH-HPS at this farm.
Isolation and Identification of FAdV and CIAV
According to the same methods in previous report , 1 mL of vaccine seed was mixed well with 1 mL of NDV-specific serum (prepared by the China Institute of Veterinary Drug Control), and the mixtures were shaken and incubated at 37
• C for 60 min for neutralization and filtered through a 0.22-μm filter. The filtered solution was used to inoculate 10-day-old specific pathogen-free (SPF) embryonated chicken eggs with the mixture of FAdV and CIAV. Similar methods were applied to isolate FAdV and CIAV separately using FAdVspecific serum or CIAV-specific serum (prepared by the China Institute of Veterinary Drug Control). After repeated neutralizations, the isolate of FAdV was detected by qPCR for the existence of CIAV and NDV (Ren et al., 2016) , while the isolate of CIAV was detected by qPCR for the existence of FAdV and NDV (Jang et al., 2011; Günes et al., 2012) . The 50% embryo infectious dose (EID 50 ) of the purified viruses was calculated by the method of Reed-Muench and the virus strains were stored at −80
• C.
Maternal Antibody Detection
One-day-old HY-Line variety brown layers were purchased from a breeder farm. Sera from all chicks were collected at 1, 2, 3, 4, 5, 6, and 7-day-age to determine the concentrations of FAdV and CIAV antibody using FAdV Group I Antibody test kit (BioChek, Netherlands) and CIAV Antibody test kit (Zoetis, USA). The positive rate of FAdV maternal antibody was around 73% as well as no chick was CIAV maternal antibody positive, and then we eliminated all FAdV antibody negative chicks. At the same time, anticoagulant blood were extracted from all chicks at one-day-old for common virus detection including NDV, ALV, REV, CIAV and FAdV by qPCR (Jiang et al., 2011; Günes et al., 2012; Dai et al., 2015; Luan et al., 2016; Ren et al., 2016) .
Animal Experiments Design
After maternal antibody and common virus detection, one hundred and forty healthy layers with maternal FAdV antibody were wing banded and randomly divided into seven groups, with 20 chickens in each group, and separately bred in shielded cages with positive filtered air. Using FAdV and CIAV isolated from above-mentioned vaccine, different contaminated vaccines were artificially prepared as trial samples to vaccinate chicks orally at 7 days age. Specifically, NDV attenuated vaccine (purchased from the local animal vaccines market and showing all negative in abovementioned pathogens test) was diluted with normal saline according to the instructions, and the final volume of each plume was around 200 μL. Afterwards, FAdV or CIAV isolates were diluted with normal saline to 50EID 50 /μL as well as 10EID 50 /μL and then added into each plume of diluted vaccine. Specific groups and treatments are shown in Table 1 .
Measurement of Body Weight and Immune Organs Indices
To compare the effects of viral infection on growth retardation and immunosuppression, the growth and death of the chicks were measured daily. Individual body weights (BWs) were measured at weeks 1, 2, 3, 4, 5, and 6 in the seven groups of the experiment. At 6 weeks of age, all chicks were euthanized according to the animal care and use protocol, and the tissues were collected including the thymus, spleen, and bursa of Fabricius and preserved at −80
• C. After weighing the organs, the immune organ indices of the thymus, spleen, and bursa of Fabricius were calculated as organ weight (wet weight, mg)/BW (g) × 100%. 
Quantification of Viremia of FAdV and CIAV
Anticoagulant blood from all chicks was collected at 10-day-old and weeks 2, 3, 4, and 5 of the experiment for DNA extraction to determine the viremia levels of FAdV and CIAV using published qPCR methods (Günes et al., 2012; Ren et al., 2016) . For conforming virus copy numbers in above samples, viral DNA concentration (Log 10 ) was normalized per 1 μg of the total DNA. The qPCR reactions were set up on ice, and an ABI PRISMR 7500 Sequence Detection System (Applied Biosystems, USA) was used to amplify and detect the reaction products. The qPCR was performed in duplicate, with each sample present in technical duplicate during each run.
Antibody Responses to NDV, FAdV and CIAV
Sera from all chicks were collected at weeks 2, 3, 4, 5, and 6 of the experiment for haemagglutination inhibition testing to determine the concentrations of NDV antibody in accordance with the routine procedures, while the FAdV and CIAV antibody levels of those samples were also determined using the FAdV Group I Antibody test kit (BioChek, Netherlands) and CIAV Antibody test kit (Zoetis, USA) according to the instructions.
Statistical Analysis
Statistical analysis was performed using the SPSS statistical software package for windows version 17.0 (SPSS Inc. Chicago, Illinois, USA). P < 0.05 was considered statistically significant based on Duncan's multiple-range test.
RESULTS
FAdV and CIAV Vaccine Isolate were Isolated Successfully
After repeated serum neutralizations, chick embryo inoculation and separations, the FAdV and CIAV vaccine isolate were successfully isolated from the contaminated attenuated NDV vaccine. The FAdV was determined by qPCR to be pure without ALV, REV, CIAV, and NDV, while the CIAV was confirmed to be pure without ALV, REV, FAdV, and NDV. In addition, the FAdV vaccine strain was then determined to be FAdV-4 by sequencing and analysis of its hexon gene according to methods used in previous study (Li et al., 2017) .
Mortality Rates and Clinical Symptom
During the experiments, no chicks died after using the NDV-attenuated vaccine without contamination or singly contaminated with FAdV or CIAV, which indicated that the use of NDV-attenuated vaccine contaminated with a low dose of FAdV or CIAV could not cause death. Chicks that received the attenuated NDV vaccine contaminated with both FAdV and CIAV began to die starting at about 25 days of age with a final mortality rate of 10% (2/20, group FAdV/CIAV/L) and 15% (3/20, group FAdV/CIAV/H) (Table 2, Figure 1 ). More importantly, IBH-HPS appeared in chicks that received the attenuated NDV vaccine contaminated with both FAdV and CIAV (Table 2, Figure 2A-B) .
Body Weight
In this study, the growth rate of chicks receiving different contaminated vaccines was decreased. In the high-dose experiment ( Figure 3A) , the BWs of the chicks in the group FAdV/H was close to that of the group control (P > 0.05), while the BWs of the chicks in the group CIAV/H was significantly lower than that of the group control since three weeks of age (P < 0.05). More importantly, the BWs of the chicks in the group FAdV/CIAV/H was significantly lower than that of the other groups since four weeks of age (P < 0.05). The results of the low-dose experiment were similar to the above results ( Figure 3B ).
Immune Organs Indices
The immune organs affected by the contaminated attenuated NDV vaccine showed different degrees of injury, including splenomegaly and thymus gland atrophy. In the high-dose experiment (Figure 4A ), the immune organ indices of the chicks in the group FAdV/H were similar to that of the group control (P > 0.05), while severe splenomegaly and atrophy of the thymus gland was present in the group FAdV/CIAV/H, and the corresponding indices were significantly different from that of the other groups (P < 0.05). Meanwhile, obvious splenomegaly and atrophy of the thymus gland also appeared in the group CIAV/H (P < 0.05). The results of the low-dose group experiments were consistent with the above results ( Figure 4B ), but the spleen indices of the chicks in the group CIAV/L were similar to that of the control group (P > 0.05).
The Viremia Levels of FAdV and CIAV in Each Group
To assess the interaction of FAdV and CIAV and discover why their simultaneous infection caused severe diseases and high mortality, we determined the viremia levels of FAdV and CIAV in different groups. In the high dose experiment, the viremia levels of FAdV of the group FAdV/H were significantly lower than that of the group FAdV/CIAV/H at the 10 days age (P < 0.05) and disappeared immediately since two weeks age ( Figure 5A ), while the viremia levels of CIAV of the group CIAV/H were always close to that of the group FAdV/CIAV/H with little difference in the whole experiment ( Figure 5C ). And the results of the low-dose group experiments were consistent with the above results ( Figure 5B and C) . All organs were harvested 6 weeks post hatched, which was represented as Organ weight/body weight × 1000 (Mean ± error). Different lowercase superscript letters indicate that the difference is statistically significant within a column (P < 0.05) based on Duncan's multiple-range test. Figure 5 . The viremia levels of FAdV (A: high-dose. B: low-dose), and CIAV (C: high-dose; D: low-dose). The viremia level value (mean ± error) of the co-contaminated group was compared with that of the corresponding singly contaminated group based on Duncan's multiple-range test.
* Indicates significant difference (P < 0.05) between the two experimental groups.
Antibody Responses to Vaccination Against NDV
As shown in Figure 6A , the suppressive effect on antibody production against NDV varied between the single contamination and co-contamination of the vaccine. The suppressive effect of the group FAdV/CIAV/H was significantly higher than that of group CIAV/H (P < 0.05), but the difference between the group FAdV/H and the group control was not significantly (P > 0.05). The results of the low-dose group experiments were consistent with the above results ( Figure 6B ). Sera from all chicks were collected at different intervals of the experiment for haemagglutination inhibition testing to determine the concentrations of NDV antibody, which was represented as Log 2 NDV antibody titer (Mean value ± error). Different lowercase superscript letters indicate that the difference is statistically significant within a column (P < 0.05) based on Duncan's multiple-range test.
Antibody Level of FAdV and CIAV in Different Groups
With the assimilation of the yolk, the maternal FAdV antibody level increased gradually and peaked at three days age, but then dropped swiftly ( Figure 7A ). After receiving high doses of the contaminated vaccines for one week, FAdV antibody levels increased in group FAdV/H and group FAdV/CIAV/H, but FAdV antibody levels in the group FAdV/H were significantly higher than that of the group FAdV/CIAV/H in the early infection period (P < 0.05), which demonstrated that CIAV could decrease FAdV antibody production and provide a chance for FAdV to multiply. However, the increases in FAdV antibody levels in the FAdV/H group disappeared immediately since 21-day-old, while that of the FAdV/CIAV/H group continued to increase slightly without any decline, which was significantly higher than either the group FAdV/H or the group control since 28-day-old (P < 0.05, Figure 7A ). It also demonstrated the chronic existence of FAdV, in vivo. The CIAV antibody levels of the CIAV/H group was higher overall than that of the FAdV/CIAV/H group during the early period after vaccination, which peaked at three weeks of age ( Figure 7C) . Sera from the control and FAdV group chicks were found to be CIAV antibody negative (Data not show). The results of the low-dose group experiments were consistent with that of the control and FAdV groups ( Figure 7B and D) .
DISCUSSION
IBH-HPS is characterized by the accumulation of fluid in the pericardial sac, necrotic hepatitis, high morbidity and severe mortality. It was first reported in broiler birds, 3 to 5 weeks of age from Angara Goth, near Karachi, Pakistan, in 1987 and is therefore commonly known as 'Angara Disease' (Khawaja et al., 1988; Cheema et al., 1989 Anjum et al., 1989 ) and has caused huge economic losses to all over the world including India (Gowda and Satyanarayana, 1994) , Japan (Abe et al., 1998) , Mexico, Chile, Ecuador, Peru (Cowen et al., 1996; Shane, 1996; Voss et al., 1996; Toro et al., 1999) , Russia (Borisov et al., 1997) , Slovakia (Jantosovic et al., 1991) , Bangladesh (Biswas et al., 2002) , Korea (Kim et al., 2008) . IBH-HPS was introduced into China in 1997, but gained little attention since it was not largely prevalent at that time. However, this disease has appeared in Shandong, Henan, Hebei, and other provinces of China with an annually increasing trend in the past five years and is still an epidemic at present (Zhang et al., 2016; Liu et al., 2016; Chen et al., 2017; Pan et al., 2017) .
While the source of infection for the prevalence of IBH-HPS in many regions of China is still unclear, the use of attenuated vaccines contaminated with FAdV is suspected to be one. In previous study, the contamination of FAdV-4, which was found to be highly consistent with the field strain JSJ13, as per the sequence analysis of the hexon gene, was detected in some attenuated vaccines (Li et al., 2017) . Further, genome sequence analysis revealed that SCMY16, a FAdV-4 strain isolated in the Sichuan province of China, which might also have come from a contaminated vaccine, exhibited 99% identity with JSJ13 (Guan, et al., 2016) .
Immunity by inactivated vaccine is an effective method for FAdV-prevention (Kim et al., 2014; Schachner et al., 2014) . Currently, in most flocks, FAdV inactivated vaccine has been used, which not only effectively protects the parental chickens against FAdV but also their offsprings by maternal antibodies. However, offspring chicks of a layer breeding flocks with vaccination of inactivated FAdV still got infected by FAdV-4 and had IBH-HPS. Analysis revealed that the NDV attenuated vaccine used in that farm was simultaneously contaminated with FAdV-4 and CIAV. But the dose of exogenous virus contamination in attenuated vaccine was extremely low in the ordinary course of events, and people firmly believed that the maternal antibody could protect chicks against it. Accordingly, animal experiments were launched to observe the pathogenicity of different contaminated NDV attenuated vaccine toward layers with FAdV maternal antibody.
Throughout the experiment, no chick died after using the NDV attenuated vaccine without contamination and singly contaminated with FAdV or CIAV, while about 10%-15% mortality and IBH-HPS appeared in co-contaminated group. Those findings were consistent with data from practical production and illustrated that the use of such co-contaminated vaccine was an important reason for the outbreak of IBH-HPS. Meanwhile, many indices were also employed to estimate the auxo-action of CIAV for the pathogenicity of vaccine with FAdV contaminations. The growth rate, immune system organ indices, and NDV antibody level of the FAdV singly contaminated groups were similar to controls, and the viremia of FAdV in those groups disappeared after two weeks post vaccination, which suggested that the single FAdV in contaminated vaccine might be annihilated by the joint effect of maternal antibody and the immune system. However, growth retardation, splenomegaly, and atrophy of the thymus gland appeared in chicks after using CIAV contaminated group with a slump in NDV antibody level, which indicated that CIAV infection from contaminated vaccine could hinder the development of immune organs and inhibit the immune response of chickens, while all those effects similarly provided opportunities for FAdV to invade those chickens and then rapidly proliferate in vivo after using co-contaminated vaccine. Monitoring the FAdV and CIAV antibody levels also authenticated above ratiocination. Along with the assimilation of yolk, the maternal FAdV antibody level gradually increased after hatched and reached the peak at 3-day-old, but then dropped swiftly, which also provided some reasons behind the break of maternal antibody. Thus, we guessed that the rapid proliferation of CIAV destroyed the immune system and prevented its response to the early FAdV entrant, while maternal antibody at the time of vaccination was too sparse to purge all FAdV, which survived in some chicks and caused severe clinical symptoms and death due to IBH-HPS.
In a conclusion, this study illustrated that CIAV could help FAdV break the protection of maternal antibody and then caused severe IBH-HPS after using co-contaminated NDV attenuated vaccine, which also might be an important source of infection for FAdV and CIAV. Information from this study would promote the further understand of the interaction of FAdV and CIAV and provide theoretical basis for the prevention and cure of IBH-HPS, and vaccine producers should guarantee that no exogenous virus is in their vaccines to avoid similar problems in the future.
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